rim_10qsb-043008.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-QSB

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2008


o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ TO __________

COMMISSION FILE NUMBER 000-21785

RIM SEMICONDUCTOR COMPANY
(Exact name of small business issuer as specified in its charter)


UTAH
 
95-4545704 
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
identification no.)



305 NE 102ND AVENUE, SUITE 350
PORTLAND, OREGON 97220
 
(503) 257-6700
(Address of principal executive offices)
 
(Issuer’s telephone number,
including area code) 



Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes x  No o 
   
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act)
Yes o   No x
   
The number of shares of the issuer’s Common Stock, par value $.001 per share, outstanding as of June 20, 2008, was 891,745,161.
 
   
Transitional Small Business Disclosure Format (Check one)
Yes o   No x


 
 

 

FORM 10-QSB

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY COMMENCING NOVEMBER 1, 2007)

APRIL 30, 2008

TABLE OF CONTENTS


 
PAGE
PART I - FINANCIAL INFORMATION
1
     
ITEM 1.  FINANCIAL STATEMENTS
1
     
 
CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) At April 30, 2008
1
     
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the Six and Three Months Ended April 30, 2008 and 2007 and for the Period From November 1, 2007 (Date of Commencement as a Development Stage Company) to April 30, 2008
2
     
 
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (Unaudited) For the Six Months Ended April 30, 2008
4
     
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the Six Months Ended April 30, 2008 and 2007 and for the Period From November 1, 2007 (Date of Commencement as a Development Stage Company) to April 30, 2008
10
     
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
13
     
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
35
     
ITEM 3.  CONTROLS AND PROCEDURES
45
     
PART II - OTHER INFORMATION
46
     
ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
46
     
ITEM 5.  OTHER INFORMATION
47
     
ITEM 6.  EXHIBITS
49
   
SIGNATURES
50


 
 

 

PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED BALANCE SHEET
 (Unaudited)
   
April 30,
2008
 
ASSETS
     
       
Current Assets:
     
Cash
 
$
1,621
 
Other current assets
   
43,104
 
Assets of discontinued operations
   
120
 
TOTAL CURRENT ASSETS
   
44,845
 
         
Property and equipment - net
   
172,512
 
Note receivable
   
50,000
 
Deferred financing costs - net
   
674,054
 
Other assets
   
20,738
 
TOTAL ASSETS
 
$
962,149
 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
       
         
Current Liabilities:
       
Convertible notes payable
 
$
478,000
 
Notes payable
   
200,000
 
Convertible debentures (net of debt discount of $2,823,307)
   
1,358,751
 
Derivative liabilities – warrants, options and embedded conversion options
   
3,311,446
 
Accounts payable and accrued expenses
   
1,615,728
 
Advance from officer
   
49,000
 
Liabilities of discontinued operations
   
838
 
TOTAL CURRENT LIABILITIES
   
7,013,763
 
         
TOTAL LIABILITIES
   
7,013,763
 
         
Commitments, Contingencies and Other matters
       
         
Stockholders’ Deficiency:
       
Preferred stock - $0.01 par value; Authorized - 15,000,000 shares; Issued - 0 shares;
Outstanding - 0 shares
   
-
 
Common stock - $0.001 par value; Authorized - 900,000,000 shares; Issued – 731,406,911 shares;
Outstanding – 730,907,057 shares
   
731,407
 
Treasury stock, at cost - 499,854 shares
   
(7,498
)
Additional paid-in capital
   
89,765,774
 
Unearned compensation
   
(382,827
)
Accumulated deficit at October 31, 2007
   
(90,689,341
)
Deficit accumulated during the development stage
   
(5,469,129
)
TOTAL STOCKHOLDERS’ DEFICIENCY
   
(6,051,614
)
         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
 
$
962,149
 

See notes to condensed consolidated financial statements.
 
 
1

 

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

   
For the Six Months Ended
April 30,
   
Period from
November 1, 2007
(Date of
Commence-ment as a
Development
Stage Company) to
 
   
2008
   
2007
   
April 30, 2008
 
                   
OPERATING EXPENSES:
                 
Acquired in-process research and development
 
$
3,015,000
   
$
-
   
$
3,015,000
 
Amortization of technology licenses and capitalized software
development costs
   
-
     
530,666
     
-
 
Research and development expenses (including stock based
compensation of $23,932 and $443,432, respectively)
   
550,257
     
809,620
     
550,257
 
Selling, general and administrative expenses (including stock
based compensation of $1,173,025 and $1,058,791,
respectively)
   
3,059,996
     
2,847,234
     
3,059,996
 
                         
TOTAL OPERATING EXPENSES
   
6,625,253
     
4,187,520
     
6,625,253
 
                         
OPERATING LOSS
   
(6,625,253
)
   
(4,187,520
)
   
(6,625,253
)
                         
OTHER EXPENSES (INCOME):
                       
Interest income
   
(1,345
)
   
-
     
(1,345
)
Interest expense
   
1,719,335
     
2,940,517
     
1,719,335
 
Change in fair value of derivative liabilities
   
(3,123,293
   
(361,747
)
   
(3,123,293
Amortization of deferred financing costs
   
253,947
     
1,165,847
     
253,947
 
Other
   
-
     
(27,895
)
   
-
 
TOTAL OTHER EXPENSES (INCOME)
   
(1,151,356
   
3,716,722
     
(1,151,356
                         
LOSS FROM CONTINUING OPERATIONS
   
(5,473,897
)
   
(7,904,242
)
   
(5,473,897
)
                         
INCOME (LOSS) FROM DISCONTINUED OPERATIONS
   
4,768
     
(8,061
)
   
4,768
 
                         
NET LOSS
 
$
(5,469,129
)
 
$
(7,912,303
)
 
$
(5,469,129
)
                         
BASIC AND DILUTED NET LOSS PER COMMON SHARE
 
$
(0.01
)
 
$
(0.02
)
       
                         
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING
   
545,462,176
     
410,318,226
         

See notes to condensed consolidated financial statements.
 
 
2

 

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

 
   
For the Three Months Ended
April 30,
 
   
2008
   
2007
 
             
OPERATING EXPENSES:
           
Acquired in-process research and development
 
$
1,675,000
   
$
-
 
Amortization of technology licenses and capitalized software
development costs
   
-
     
270,363
 
Research and development expenses (including stock based
compensation of $13,582 and $23,022, respectively)
   
130,845
     
161,946
 
Selling, general and administrative expenses (including stock based
compensation of $460,805 and $589,382, respectively)
   
1,490,912
     
1,407,759
 
                 
TOTAL OPERATING EXPENSES
   
3,296,757
     
1,840,068
 
                 
OPERATING LOSS
   
(3,296,757
)
   
(1,840,068
)
                 
OTHER EXPENSES (INCOME):
               
Interest income
   
(93
)
   
-
 
Interest expense
   
604,197
     
154,016
 
Change in fair value of derivative liabilities
   
(2,846,664
   
(1,900,394
Amortization of deferred financing costs
   
116,858
     
41,161
 
Other
   
-
     
(13,352
TOTAL OTHER EXPENSES (INCOME)
   
(2,125,702
   
(1,718,569
                 
LOSS FROM CONTINUING OPERATIONS
   
(1,171,055
)
   
(121,499
)
                 
INCOME (LOSS) FROM DISCONTINUED OPERATIONS
   
(1,987
   
(320
)
                 
NET LOSS
 
$
(1,173,042
)
 
$
(121,819
)
                 
BASIC AND DILUTED NET LOSS PER COMMON SHARE
 
$
(0.00
)
 
$
(0.00
)
                 
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING
   
618,379,072
     
425,197,451
 
 
 
See notes to condensed consolidated financial statements.
 
 
3

 

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)

 
 
Common Stock 
 
Treasury Stock 
                       
 
Shares 
   
Amount 
 
Shares 
   
Amount 
   
Additional
Paid-in
Capital 
 
Unearned Compensation 
   
Accumulated
Deficit 
   
Total
Stockholders’
Deficiency 
 
                                           
Balance at November 1, 2007
468,986,043
 
$
468,986
 
(499,854
)
$
(7,498
)
$
85,276,802
$
(907,656
)
$
(90,689,341
)
$
(5,858,707
)
Issuance of common stock under service and consulting agreement on December 19, 2007 ($0.021 per share)
5,000,000
   
5,000
 
-
   
-
   
100,000
 
(105,000
)
 
-
   
-
 
Issuance of common stock under service and consulting agreements on December 20, 2007 ($0.021 per share)
1,000,000
   
1,000
 
-
   
-
   
20,000
 
(21,000
 )
 
-
   
-
 
Issuance of common stock under service and consulting agreements on February 29, 2008 ($0.023 per share)
15,000,000
   
15,000
 
-
   
-
   
330,000
 
(345,000
 )
 
-
   
-
 
Issuance of common stock for conversion of accrued interest  on December 31, 2007 ($0.0179 per share)
1,295,944
   
1,296
 
-
   
-
   
21,837
 
-
   
-
   
23,133
 
Issuance of common stock for cash on November 6, 2007 ($0.05 per share)
400,000
   
400
 
-
   
-
   
19,600
 
-
   
-
   
20,000
 
Issuance of common stock for cash on February 1, 2008 ($0.04 per share)
950,000
   
950
 
-
   
-
   
37,050
 
-
   
-
   
38,000
 

See notes to condensed consolidated financial statements.
 
4

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)
 

 
Common Stock
 
Treasury Stock
                 
 
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Unearned Compensation
 
Accumulated
Deficit
 
Total
Stockholders’
Deficiency
 
                                 
Issuance of common stock for cash on February 15, 2008 ($0.04 per share)
500,000
   
500
 
-
   
-
   
19,500
   
-
   
-
   
20,000
 
Issuance of common stock for cash on February 21, 2008 ($0.04 per share)
500,000
   
500
 
-
   
-
   
19,500
   
-
   
-
   
20,000
 
Issuance of common stock for cash on March 19, 2008  ($0.04 per share)
500,000
   
500
 
-
   
-
   
19,500
   
-
   
-
   
20,000
 
Issuance of common stock for cash on April 4, 2008  ($0.01 per share)
2,500,000
   
2,500
 
-
   
-
   
22,500
   
-
   
-
   
25,000
 
Issuance of common stock for cash on April 9, 2008  ($0.01 per share)
1,000,000
   
1,000
 
-
   
-
   
9,000
   
-
   
-
   
10,000
 
Issuance of common stock for cash on April 11, 2008  ($0.01 per share)
3,500,000
   
3,500
 
-
   
-
   
31,500
   
-
   
-
   
35,000
 
Issuance of common stock for cash on April 15, 2008  ($0.01 per share)
2,500,000
   
2,500
 
-
   
-
   
22,500
   
-
   
-
   
25,000
 
Issuance of common stock for cash on April 28, 2008  ($0.01 per share)
6,000,000
   
6,000
 
-
   
-
   
54,000
   
-
   
-
   
60,000
 

See notes to condensed consolidated financial statements.
 
5

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)
 

 
Common Stock
 
Treasury Stock
                 
 
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Unearned Compensation
 
Accumulated
Deficit
 
Total
Stockholders’
Deficiency
 
                                 
Issuance of common stock for conversion of convertible debentures and accrued interest on February 29, 2008 ($0.0155 per share)
2,098,709
   
2,099
 
-
   
-
   
30,431
   
-
   
-
   
32,530
 
Issuance of common stock for conversion of convertible debentures and accrued interest on March 14, 2008 ($0.01617 per share)
673,698
   
674
 
-
   
-
   
10,220
   
-
   
-
   
10,894
 
Issuance of common stock for conversion of convertible debentures and accrued interest on March  18, 2008 ($0.01449 per share)
1,279,424
   
1,279
 
-
   
-
   
17,260
   
-
   
-
   
18,539
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 4, 2008 ($0.01022 per share)
996,113
   
996
 
-
   
-
   
9,184
   
-
   
-
   
10,180
 
Issuance of common stock for conversion of accrued interest on April 4, 2008 ($0.008925 per share)
465,574
   
466
 
-
   
-
   
3,689
   
-
   
-
   
4,155
 
Issuance of common stock for conversion of accrued interest on April 8, 2008 ($0.008925 per share)
138,138
   
138
 
-
   
-
   
1,095
   
-
   
-
   
1,233
 

See notes to condensed consolidated financial statements.
 
6

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)
 

 
Common Stock
 
Treasury Stock
                 
 
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Unearned Compensation
 
Accumulated
Deficit
 
Total
Stockholders’
Deficiency
 
                                 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 8, 2008 ($0.00945 per share)
1,062,551
   
1,062
 
-
   
-
   
8,978
   
-
   
-
   
10,040
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 9, 2008 ($0.00945 per share)
15,944
   
16
 
-
   
-
   
135
   
-
   
-
   
151
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 11, 2008 ($0.00917 per share)
1,111,845
   
1,112
 
-
   
-
   
9,084
   
-
   
-
   
10,196
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 14, 2008 ($0.0091 per share)
2,242,059
   
2,242
 
-
   
-
   
18,161
   
-
   
-
   
20,403
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 15, 2008 ($0.00903 per share)
1,129,932
   
1,130
 
-
   
-
   
9,073
   
-
   
-
   
10,203
 
Issuance of common stock for conversion of convertible debentures and accrued interest on April 21, 2008 ($0.0091 per share)
560,937
   
561
 
-
   
-
   
4,544
   
-
   
-
   
5,105
 

See notes to condensed consolidated financial statements.
 
7

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)
 

 
Common Stock
 
Treasury Stock
                 
 
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Unearned Compensation
 
Accumulated
Deficit
 
Total
Stockholders’
Deficiency
 
                                 
Issuance of common stock upon acquisition of BDSI on January 29, 2008 ($0.029 per share)
60,000,000
   
60,000
 
-
   
-
   
1,680,000
   
-
   
-
   
1,740,000
 
Issuance of common stock upon acquisition of MCCI on March 24, 2008 ($0.013167 per share)
150,000,000
   
150,000
 
-
   
-
   
1,825,000
   
-
   
-
   
1,975,000
 
Stock based compensation expense recognized for the granting and vesting of options to employees and advisory board members
-
   
-
 
-
   
-
   
201,128
   
-
   
-
   
201,128
 
Reclassification of warrants issued in connection with restricted common stock to derivative liability
-
   
-
 
-
   
-
   
(142,563
)
 
-
   
-
   
(142,563
Reclassification of conversion option liability
-
   
-
 
-
   
-
   
39,429
   
-
   
-
   
39,429
 
Stock-based compensation expense related to reset of conversion terms
-
   
-
 
-
   
-
   
37,637
   
-
   
-
   
37,637
 

See notes to condensed consolidated financial statements.
 
8

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)
 
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
For The Six Months Ended April 30, 2008
(Unaudited)
 

 
Common Stock
 
Treasury Stock
                 
 
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Unearned Compensation
 
Accumulated
Deficit
 
Total
Stockholders’
Deficiency
 
                                 
Amortization of unearned compensation expense
-
   
-
 
-
   
-
   
-
   
995,829
   
-
   
995,829
 
Net Loss
-
   
-
 
-
   
-
   
-
   
-
   
(5,469,129
)
 
(5,469,129
)
Balance at April 30, 2008
731,406,911
 
$
731,407
 
(499,854
)
$
(7,498
)
$
89,765,774
 
$
(382,827
)
$
(96,158,470
)
$
(6,051,614

 

 
Accumulated deficit as of October 31, 2007
 
$
(90,689,341
Deficit accumulated during the development stage
   
(5,469,129
Total accumulated deficit as of April 30, 2008
 
$
(96,158,470

See notes to condensed consolidated financial statements.
 
9

 

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
   
For the Six Months Ended
April 30,
   
Period from
November 1, 2007
(Date of Commencement as a Development
Stage Company) to
 
   
2008
   
2007
   
April 30, 2008
 
                   
CASH FLOWS FROM OPERATING ACTIVITIES
                 
Net loss from continuing operations
 
$
(5,473,897
)
 
$
(7,904,242
)
 
$
(5,473,897
)
Adjustments to reconcile net loss from continuing operations
to net cash used in operating activities:
                       
Consulting fees and other compensatory elements of stock
issuances
   
1,196,957
     
1,502,223
     
1,196,957
 
Change in fair value of derivative liabilities
   
(3,123,293
   
(361,747
   
(3,123,293
Acquired in-process research and development
   
3,015,000
     
-
     
3,015,000
 
Fair value of warrants in excess of debt discount
   
369,721
     
-
     
369,721
 
Interest expense related to reset of conversion rate on
convertible debentures
   
37,637
     
-
     
37,637
 
Increase in principal of convertible debentures in exchange for
extension of maturity date
   
40,000
     
-
     
40,000
 
Amortization of deferred financing costs
   
253,947
     
1,165,847
     
253,947
 
Amortization of debt discount on notes
   
1,115,471
     
2,893,510
     
1,115,471
 
Amortization of technology license and capitalized software
development fees
   
-
     
530,666
     
-
 
Depreciation
   
17,370
     
9,438
     
17,370
 
Other non-cash expense
   
-
     
614
     
-
 
Change in assets:
                       
Other current assets
   
50,256
     
(52,779
   
50,256
 
Other assets
   
(2,256
   
-
     
(2,256
Change in liabilities:
                       
Accounts payable and accrued expenses
   
(78,896
)
   
294,890
     
(78,896
)
NET CASH USED IN OPERATING ACTIVITIES
   
(2,581,983
)
   
(1,921,580
)
   
(2,581,983
)
                         
CASH FLOWS FROM INVESTING ACTIVITIES
                       
Proceeds from sale of trademark rights
   
-
     
200,000
     
-
 
Proceeds from maturity of short-term investments
   
-
     
1,000,000
     
-
 
Cash acquired in connection with common stock issued upon
acquisition of BDSI
   
400,000
     
-
     
400,000
 
Cash acquired in connection with common stock issued upon
acquisition of MCCI
   
300,000
     
-
     
300,000
 
Acquisition and costs of capitalized software and development
fees
   
-
     
(526,787
)
   
-
 
Acquisition of property and equipment
   
(9,250
)
   
(112,419
)
   
(9,250
)
NET CASH PROVIDED BY INVESTING ACTIVITIES
   
690,750
     
560,794
     
690,750
 
                         

See notes to condensed consolidated financial statements.
 
10

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

 
     
For the Six Months Ended
April 30, 
       
Period from
November 1, 2007
(Date of Commencement as a Development
Stage Company) to
 
     
2008 
     
2007
        April 30, 2008  
                         
CASH FLOWS FROM FINANCING ACTIVITIES
                       
Proceeds from issuance of common stock
   
273,000
     
300,000
     
273,000
 
Proceeds from convertible debentures
   
3,175,000
     
-
     
3,175,000
 
Proceeds from notes payable
   
-
     
300,000
     
-
 
Advance from officer
   
49,000
     
-
     
49,000
 
Capitalized financing costs
   
(345,000
   
(34,000
 )
   
(345,000
Repayments of notes payable
   
(1,300,000
   
-
     
(1,300,000
NET CASH PROVIDED BY FINANCING ACTIVITIES
   
1,852,000
     
566,000
     
1,852,000
 
                         
DECREASE IN CASH AND CASH EQUIVALENTS
FROM CONTINUING OPERATIONS
   
(39,233
)
   
(794,786
)
   
(39,233
)
                         
CASH FLOWS FROM DISCONTINUED OPERATIONS
– OPERATING CASH FLOWS
   
5,486
     
(8,061
)
   
5,486
 
                         
DECREASE IN CASH
   
(33,747
)
   
(802,847
)
   
(33,747
)
                         
CASH – BEGINNING OF PERIOD
   
35,368
     
1,090,119
     
35,368
 
                         
CASH – END OF PERIOD
 
$
1,621
   
$
287,272
   
$
1,621
 


See notes to condensed consolidated financial statements.

 
11

 

RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

   
For the Six Months Ended
April 30,
   
Period from
November 1, 2007 (Date of Commencement as
Development
Stage
Company) to
 
   
2008
   
2007
   
April 30, 2008
 
                   
Supplemental Disclosure of Cash Flow Information:
                 
Cash paid during the period for:
                 
Interest
 
$
31,833
   
$
50,000
   
$
31,833
 
                         
Non-Cash Investing and Financing Activities:
                       
                         
Value recorded as debt discount relating to warrants issued to purchasers
of convertible debentures
 
$
2,116,667
   
$
-
   
$
2,116,667
 
Value assigned to conversion option liability in connection with issuance
of convertible debentures
 
$
1,058,333
   
$
-
   
$
1,058,333
 
Value assigned to warrants issued in connection with notes payable
 
$
-
   
$
226,567
   
$
-
 
Value assigned on issuance date to warrants issued to finder
 
$
497,277
   
$
-
   
$
497,277
 
Common stock issued for conversion of convertible debentures, notes
payable and accrued interest
 
$
156,762
   
$
4,069,232
   
$
156,762
 
Issuance of common stock upon exercise of stock options for the
settlement of vendor payables
 
$
-
   
$
19,140
   
$
-
 
Common stock issued for accrued liquidated damages
 
$
-
   
$
68,547
   
$
-
 
Reclassification of derivative liability to equity upon exercise of options
 
$
-
   
$
71,521
   
$
-
 
                         
Reclassification of conversion option liability to equity
 
$
39,429
   
$
1,685,266
   
$
39,429
 
                         
Issuance of common stock upon acquisition of BDSI:
                       
Cash acquired
 
$
400,000
   
$
-
   
$
400,000
 
Acquired license to patented technology (research and development)
   
1,340,000
     
-
     
1,340,000
 
Fair value of common stock issued upon acquisition of BDSI
 
$
1,740,000
   
$
-
   
$
1,740,000
 
                         
Issuance of common stock upon acquisition of MCCI:
                       
Cash acquired
 
$
300,000
   
$
-
   
$
300,000
 
Acquired license to patented technology (research and development)
   
1,675,000
     
-
     
1,675,000
 
Fair value of common stock issued upon acquisition of MCCI
 
$
1,975,000
   
$
-
   
$
1,975,000
 

See notes to condensed consolidated financial statements.

 
12

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 1 - PRINCIPLES OF CONSOLIDATION AND BUSINESS OPERATIONS

The consolidated financial statements include the accounts of Rim Semiconductor Company and its wholly-owned operating subsidiaries, NV Entertainment, Inc. (“NV Entertainment”), Broadband Distance Systems, Inc. (“BDSI”), and Multi-Carrier Communications, Inc. (“MCCI”) (see Note 3) (collectively, the “Company”). Top Secret Productions, LLC is a 50% owned subsidiary of NV Entertainment. All significant intercompany balances and transactions have been eliminated. The Company consolidates its 50% owned subsidiary Top Secret Productions, LLC due to the Company’s control of management and financial matters of such entity, including all of the risk of loss.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting only of those of a normal recurring nature, necessary for a fair presentation of the Company’s financial position, results of operations and cash flows at the dates and for the periods indicated. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes related thereto included in the Annual Report on Form 10-KSB/A for the fiscal year ended October 31, 2007, filed with the Securities and Exchange Commission on February 13, 2008.

These results for the six months ended April 30, 2008 are not necessarily indicative of the results to be expected for the full fiscal year. The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Rim Semiconductor Company was incorporated under the laws of the State of Utah on December 5, 1985. In November 1999, the Company began to focus its business activities on the development of new semiconductor technologies. Pursuant to such plan, in February 2000, the Company acquired NV Technology, Inc. and commenced its technology business. The Company’s technology business has developed advanced transmission technology products that enable data to be transmitted across copper telephone wire at speeds and over distances that exceed those offered by leading DSL technology providers. The Company’s technology business has generated no revenues to date.

The Company operated in two business segments until December 2007 when the Company discontinued the operations of its Entertainment Segment and accordingly re-entered the development stage as defined in Statement of Financial Accounting Standards (“SFAS”) No. 7, “Accounting and Reporting for Development Stage Companies” (“SFAS No. 7”). The remaining segment (Semiconductor Segment) will have no operating revenues until successful commercialization of its developed technology and will continue to incur substantial operating expenses, capitalized costs and operating losses. As a result of the discontinuation of the Entertainment Segment, the Semiconductor Segment is the Company’s only reporting segment.

The income (loss) from discontinued operations was $(1,987) and $(320) for the three months ended April 30, 2008 and 2007, respectively, and $4,768 and $(8,061) for the six months ended April 30, 2008 and 2007, respectively.  There were no film distribution royalties from the Entertainment Segment for the three months ended April 30, 2008 and 2007, respectively, and $8,379 and $0 for the six months ended April 30, 2008 and 2007, respectively, and were recorded within the income (loss) from discontinued operations.  The income (loss) on discontinued operations did not impact basic and diluted net loss per common share for the three and six months ended April 30, 2008 and 2007.

Assets of the Entertainment Segment consist entirely of cash as of April 30, 2008 and have been recorded as a current asset under the caption “Assets of discontinued operations” in the accompanying balance sheets.  Liabilities of the Entertainment Segment consist entirely of accounts payable and accrued expenses as of April 30, 2008 and have been recorded as a current liability under the caption “Liabilities of discontinued operations” in the accompanying balance sheet.

 
13

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 1 - PRINCIPLES OF CONSOLIDATION AND BUSINESS OPERATIONS (CONTINUED)

Liquidity Discussion

The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business.

The carrying amounts of assets and liabilities presented in the financial statements do not purport to represent realizable or settlement values. The Company has suffered significant recurring operating losses, used substantial funds in its operations, and needs to raise additional funds to accomplish its business plan.  For the three months ended April 30, 2008 and 2007 the Company incurred net losses of approximately $1.2 million and $122,000, respectively, and approximately $5.5 million and $7.9 million for the six months ended April 30, 2008 and 2007, respectively.  As of April 30, 2008, the Company had a working capital deficiency of approximately $7.0 million and a stockholders’ deficiency of approximately $6.1 million.  In addition, management believes that the Company will continue to incur net losses and cash flow deficiencies from operating activities through at least April 30, 2009.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s ability to continue to operate as a going concern is dependent on its ability to generate sufficient cash flows to meet its obligations on a timely basis, to obtain additional financing and to ultimately attain profitability.

Interest payments of approximately $193,000 are due June 30, 2008 on the Company’s 10% Secured Convertible Notes (the “2007 Debentures”).  The Company does not presently have sufficient funds to make these interest payments.  If it cannot raise sufficient funds to make the interest payments by July 8, 2008, or reach an agreement with its lenders to extend the interest payment date, the Company would be in default on the 2007 Debentures, which are secured by substantially all of the Company’s assets, including its intellectual property.  The Company also has unsecured debt that is either past due or will be due between June 2008 and September 2008.  It requires additional financing or accommodations from its lenders to satisfy these obligations or avoid or waive a default.

In December 2007, the Company received net proceeds of approximately $1.7 million from the sale of its 2007 Debentures (see Note 5).  On January 29, 2008, the Company acquired all of the issued and outstanding stock of BDSI.  Upon closing of the acquisition transaction, BDSI had $400,000 in cash and a worldwide exclusive license to patented technology developed by researchers at the University of Illinois.  On March 24, 2008, the Company acquired all of the issued and outstanding stock of MCCI (see Note 3).  Upon closing of the acquisition transaction, MCCI had $300,000 in cash and a worldwide exclusive license to certain technology owned by The University of Queensland & The University of Sydney and UNIQUEST Pty Limited (“Uniquest”).

During the six months ended April 30, 2008, the Company received cash proceeds of $273,000 from the sale of 18,350,000 shares of restricted common stock and warrants to purchase 17,503,759 shares of common stock.

Management of the Company is continuing its efforts to secure funds through equity and/or debt instruments for its operations.  The Company will require additional funds for its operations and to pay down its liabilities, exploit the patent licenses held by BDSI or MCCI, and finance its expansion plans consistent with its business plan.  However, there can be no assurance that the Company will be able to secure additional funds and that if such funds are available, whether the terms or conditions would be acceptable to the Company and whether the Company will be able to turn into a profitable position and generate positive operating cash flow.  The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty and these adjustments may be material.


 
14

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Estimates

The preparation of the condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes.  Significant estimates include impairment analysis for long-lived assets, income taxes, litigation and valuation of derivative instruments. Actual results could differ from those estimates.

Research and Development

Research and development costs are charged to expense as incurred. Amounts allocated to acquired-in-process research and development costs, from business combinations, are charged to operations at the consummation of the acquisition.

Research and development expenses relate to the design and development of advanced transmission technology products.  In the past, the Company has outsourced its design and development activities to independent third parties, although it is not currently doing so. Internal development costs and payments made to independent software developers under development agreements are capitalized to software development costs once technological feasibility is established or if the development costs have an alternative future use.  Prior to establishing technological feasibility, development costs and payments made are expensed to research and development costs. Technological feasibility is evaluated on a product-by-product basis.

Research and development expenses generally consist of salaries, related expenses for engineering personnel and third-party development costs incurred.

Derivative Financial Instruments

In connection with the issuance of certain convertible debentures (see Note 5), the terms of the debentures included an embedded conversion feature which provided for a conversion of the debentures into shares of the Company’s common stock at a rate which was determined to be variable.  The Company determined that the conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended, and Emerging Issues Task Force (“EITF”) Issue No. 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” (“No. 00-19”).

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. In addition, under the provisions of EITF Issue No. 00-19, as a result of entering into the convertible debenture agreements, the Company was required to classify all other non-employee warrants and options as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as non-operating, non-cash income or expense at each balance sheet date.  If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company recorded a non-operating, non-cash charge.  If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company recorded non-operating, non-cash income.  The Company reassesses the classification at each balance sheet date. If the classification required under EITF Issue No. 00-19 changes as a result of events during the period, the contract should be reclassified as of the date of the event that caused the reclassification.


 
15

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Derivative Financial Instruments (Continued)

The Company accounts for embedded conversion options that no longer meet the conditions of EITF Issue No. 00-19 to be classified as a liability under EITF Issue No. 06-7, “Issuer’s Accounting for a Previously Bifurcated Conversion Option in a Convertible Debt Instrument When the Conversion Option No Longer Meets the Bifurcation Criteria in FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities” (“EITF Issue No. 06-7”).  Under EITF Issue No. 06-7, when an embedded conversion option previously accounted for as a derivative under SFAS No. 133 no longer meets the bifurcation criteria, the Company reclassifies the amount of the embedded conversion option to stockholders’ deficiency.

The fair value of derivative financial instruments was estimated during the three and six months ended April 30, 2008 and 2007 using the Black-Scholes model and the following range of assumptions:

 
Three Months Ended
April 30,
Six Months Ended
April 30,
 
 
2008
2007
2008
2007
 
Expected dividends
None
 
None
None
None
 
Expected volatility
96.0 – 146.3%
 
47.9 - 134.1%
96.0 – 146.3%
47.9 - 136.9%
 
Risk-free interest rate
1.4 – 3.3%
 
4.6 - 5.0%
1.4 – 3.7%
4.6 - 5.2%
 
Contractual term (years)
0.2 - 8.3
 
0.4 - 9.3
0.2 - 8.5
0.4 - 9.5
 

 
The expected volatility is based on a blend of the Company’s industry peer group and the Company’s historical volatility.  The risk-free interest rate assumption is based upon observed interest rates appropriate for the term of the related stock options and warrants.  The dividend yield assumption is based on the Company’s history and expectation of dividend payouts.  The expected life of stock options and warrants represents the Company’s historical experience with regards to the exercise behavior of its option and warrant holders and the contractual term of the options and warrants.

Registration Payment Arrangements

The Company accounts for registration payment arrangements in accordance with FASB Staff Position (“FSP”) No. EITF 00-19-2, “Accounting for Registration Payment Arrangements” (“FSP EITF 00-19-2”), which specifies that contingent obligations to make future payments or otherwise transfer consideration under a registration payment arrangement, should be separately recognized and measured in accordance with SFAS No. 5, “Accounting for Contingencies”.  SFAS No. 5 requires loss contingencies to be accrued and expensed if they are probable and reasonably estimable.  As of April 30, 2008, the Company has accrued $181,003 within accounts payable and accrued expenses for liquidated damages in connection with registration payment arrangements.

Loss Per Common Share

Basic loss per common share is computed based on weighted average shares outstanding and excludes any potential dilution.  Diluted loss per share reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period.  The income (loss) from discontinued operations had no significant impact on the basic and diluted net loss per common share for the three and six months ended April 30, 2008 and 2007.

 
16

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Loss Per Common Share (Continued)

For the three and six months ended April 30, 2008 and 2007, no effect has been given to outstanding options, warrants, convertible notes payable, or convertible debentures in the diluted computation, as their effect would be anti-dilutive (see Note 7).

Stock-Based Compensation

The Company reports stock based compensation under accounting guidance provided by SFAS No. 123 (revised 2004), “Share-Based Payment” (“SFAS 123(R)”), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including stock options, based on estimated fair values.
 
SFAS 123(R) requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statement of operations.  The Company has continued to attribute the value of stock-based compensation to expense on the straight-line single option method.  Stock-based compensation expense recognized under SFAS 123(R) related to employee stock options granted during the three months ended April 30, 2008 and 2007 was $101,514 and $117,183 respectively, and $201,128 and $227,948 for the six months ended April 30, 2008 and 2007, respectively.

As stock-based compensation expense recognized in the consolidated statement of operations for the three and six months ended April 30, 2008 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures.  SFAS 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation.  The reclassification did not have any effect on reported losses for any periods presented.

Impact of Recently Issued Accounting Standards

In September 2006, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the U.S., and expands disclosures about fair value measurements. SFAS 157 is effective for the Company as of the beginning of fiscal 2009, with earlier application encouraged.  Any cumulative effect will be recorded as an adjustment to the opening accumulated deficit balance, or other appropriate component of equity.  The adoption of this pronouncement is not expected to have an impact on the Company’s consolidated financial position, results of operations, or cash flows.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 provides companies with an option to report selected financial assets and liabilities at fair value.  The objective of SFAS 159 is to reduce both complexity in accounting for financial instruments and the volatility in earnings caused by measuring related assets and liabilities differently.  Generally accepted accounting principles have required different measurement attributes for different assets and liabilities that can create artificial volatility in earnings. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS 159 does not eliminate disclosure requirements included in other accounting standards, including requirements for disclosures about fair value measurements included in SFAS 157 and SFAS No. 107, “Disclosures about Fair Value of Financial Instruments.” SFAS 159 is effective for the Company as of the

 
17

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Impact of Recently Issued Accounting Standards (Continued)

beginning of fiscal year 2009.  The Company has not yet determined the impact SFAS 159 may have on its consolidated financial position, results of operations, or cash flows.

In December 2007, the FASB issued SFAS No. 141 (revised 2007), “Business Combinations” (“SFAS 141(R)”). SFAS 141 (R) replaces SFAS No. 141, “Business Combinations”, and is effective for the Company for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. SFAS 141(R) requires the new acquiring entity to recognize all assets acquired and liabilities assumed in the transactions; establishes an acquisition-date fair value for acquired assets and liabilities; and fully discloses to investors the financial effect the acquisition will have.  SFAS 141(R) would have an impact on accounting for any businesses acquired after the effective date of this pronouncement.

In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements” (“SFAS 160”).  SFAS 160 requires all entities to report minority interests in subsidiaries as equity in the consolidated financial statements, and requires that transactions between entities and noncontrolling interests be treated as equity. SFAS 160 is effective for the Company as of the beginning of fiscal 2010.  The Company is evaluating the impact of this pronouncement on the Company’s consolidated financial position, results of operations and cash flows.

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161 “Disclosure about Derivative Instruments and Hedging Activities – an amendment of FASB Statement No. 133” (“SFAS 161”).  SFAS 161 changes the disclosure requirements for derivative instruments and hedging activities.  Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under SFAS No. 133 and its related interpretations, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows.  The guidance in SFAS 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application encouraged.  This Statement encourages, but does not require, comparative disclosures for earlier periods at initial adoption.  The Company is evaluating the impact of this pronouncement on the Company’s consolidated financial position, results of operations and cash flows.

NOTE 3 – ACQUISITIONS

Acquisition of BDSI

On January 29, 2008, the Company completed its acquisition of all of the issued and outstanding capital stock of BDSI, a subsidiary of UTEK Corporation (“UTEK”) in exchange for 60,000,000 shares of unregistered common stock of the Company, valued at $1,740,000, which are subject to certain anti-dilution adjustments.  As a result of the transaction, BDSI became a wholly-owned subsidiary of the Company.  BDSI was incorporated on December 13, 2007 and its historical operations prior to acquisition were not significant.  The Company has accounted for this acquisition under the purchase method of accounting.  Upon closing of the acquisition transaction, BDSI had $400,000 of cash and a worldwide exclusive license to patented technology developed by researchers at the University of Illinois.  The remaining purchase price of $1,340,000 was allocated to the license.  As the Company recorded an impairment of its existing technology licenses and capitalized software development costs during the year ended October 31, 2007 and is currently in the development stage, management determined it was unable to currently demonstrate alternative future uses for the license and support the carrying amount of the license based upon estimated future cash flows.  Accordingly, the $1,340,000 was charged to operations, under the caption “Acquired in-process research and development” during the three months ended January 31, 2008.


 
18

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 3 – ACQUISITIONS (CONTINUED)

Acquisition of BDSI (Continued)

The patent relates to an algorithm designed to enhance power allocation in telecommunications systems that use multicarrier modulation protocol. IPSL, ADSL, VDSL and DSL systems are all examples of multicarrier modulation protocols. The algorithm serves to improve the achievable data rate or the signal-to-noise ratio, reducing errors in the transmission. Under the exclusive license agreement relating to such technology, BDSI is obligated to pay the University of Illinois royalties based on achievement of certain sales levels for products utilizing the technology. Unless earlier terminated by a party pursuant to the terms of the license agreement, the license expires upon the expiration or termination of all of the University of Illinois patent rights underlying the technology. The license agreement also permits BDSI to sublicense the technology and obligates BDSI to make royalty payments to the University of Illinois based on a percentage of payments received by BDSI from sublicensees. The Company requires additional funds in order to exploit the patent license held by BDSI.

The results of operations of BDSI have been included in the accompanying condensed consolidated financial statements from the date of acquisition.

Based on our evaluation, the allocation of the purchase price for BDSI is as follows as of January 29, 2008, the date of acquisition:

Assets and technology acquired:
     
Cash acquired
  $ 400,000  
Acquired license to patented technology (research and development)
    1,340,000  
   Total assets and technology acquired
  $ 1,740,000  

Acquisition of MCCI

On March 24, 2008, the Company completed its acquisition of all of the issued and outstanding capital stock of Multi-Carrier Communications, Inc., (“MCCI”), a subsidiary of UTEK Corporation (“UTEK”) in exchange for 150,000,000 shares of unregistered common stock of the Company, valued at $1,975,000, which are subject to certain anti-dilution adjustments.  As a result of the transaction, MCCI became a wholly-owned subsidiary of the Company. MCCI was incorporated on March 12, 2008 and its historical operations prior to acquisition were not significant.  The Company has accounted for this acquisition under the purchase method of accounting.  Upon closing of the acquisition transaction, the assets of MCCI included $300,000 in cash, and a worldwide exclusive license to certain technology owned by The University of Queensland & The University of Sydney and UNIQUEST Pty Limited (“Uniquest”).  The remaining purchase price of $1,675,000 was allocated to the license.  As the Company recorded an impairment of its existing technology licenses and capitalized software development costs during the year ended October 31, 2007 and is currently in the development stage, management determined it was unable to currently demonstrate alternative future uses for the license and support the carrying amount of the license based upon estimated future cash flows.  Accordingly, the $1,675,000 was charged to operations, under the caption “Acquired in-process research and development” during the three and six months ended April 30, 2008.

The technology relates to multiple advanced algorithms for the transmission of digital data across metallic media, such as copper wires.  Under the License Agreement (the “Uniquest License Agreement”) relating to such technology, MCCI is obligated to pay Uniquest an up-front fee and a patent reimbursement fee to cover patents costs relating to the technology. MCCI made those payments to Uniquest before the Company acquired MCCI.  The Uniquest License Agreement also provides that MCCI shall pay royalties based on achievement of certain sales levels for products utilizing the technology. Royalty obligations of MCCI are subject to certain minimum amounts. Unless earlier terminated by a party pursuant to the terms of the Uniquest License Agreement, the license expires upon the day before the date of expiration of all of the patent rights underlying the technology or 20 years from the date of the Uniquest License Agreement for unpatented technology.  The Uniquest License Agreement also permits

 
19

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 3 – ACQUISITIONS (CONTINUED)

Acquisition of MCCI (Continued)

MCCI to sublicense the technology with the consent of Uniquest and obligates MCCI to make royalty payments to Uniquest based on a percentage of payments received by MCCI from sublicensees.  MCCI and Uniquest have also entered into a Research Agreement pursuant to which MCCI shall fund and obtain certain rights relating to the licensed technology developed through a research program to be implemented by Uniquest.  MCCI funded this research before the Company acquired MCCI.  The Company requires additional funds in order to exploit the patent license held by MCCI.

The results of operations of MCCI have been included in the accompanying condensed consolidated financial statements from the date of acquisition.

Based on our evaluation, the allocation of the purchase price for MCCI is as follows as of March 24, 2008, the date of acquisition:

Assets and technology acquired:

Cash acquired
 
$
300,000
 
Acquired license to patented technology (research and development)
   
1,675,000
 
Total assets and technology acquired
 
$
1,975,000
 

NOTE 4 - DEFERRED FINANCING COSTS

As of April 30, 2008, the deferred financing costs consist of costs incurred in connection with the issuance of the Company’s outstanding debt:

Deferred financing costs
 
$
 842,277
 
Less: accumulated amortization
   
 (168,223
)
         
Deferred financing costs, net
 
$
674,054
 

Costs incurred in connection with debt financings are capitalized as deferred financing costs and amortized over the term of the related debt.  If any or all of the related debt is converted or repaid prior to its maturity date, a pro-rata share of the related deferred financing costs are written off and recorded as amortization expense in the period of the conversion or repayment in the consolidated statement of operations.  During the six months ended April 30, 2008, the Company capitalized $842,277 of deferred financing costs related to the 2007 Debentures (see Note 5).

Amortization of deferred financing costs was $116,858 and $253,947, for the three and six months ended April 30, 2008, respectively, and $41,161 and $1,165,847 for the three and six months ended April, 30, 2007, respectively.

NOTE 5 - CONVERTIBLE DEBENTURES

2007 Debentures

On December 5, 2007, the Company entered into a subscription agreement with certain institutional and individual investors pursuant to which the Company sold the 2007 Debentures and warrants to purchase shares of the Company’s common stock.  The 2007 Debentures were issued on December 5, 2007, have a term of two years and are secured by substantially all of the Company’s assets, including all of the Company’s intellectual property.  The Company has raised gross proceeds of $3,175,000 from the private placement of secured convertible notes with an aggregate principal amount of $3,527,778 (which amount reflects an original issue discount of 10%, or $352,778).

 
20

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2007 Debentures (Continued)

In connection with the issuance of the 2007 Debentures, the Company issued to the investors warrants to purchase an aggregate of 146,532,832 shares of common stock at an initial exercise price of $0.10 per share, valued at $2,486,388 on the issuance date.  The warrants are immediately exercisable at a per share exercise price of $0.10 (which is subject to adjustment) through the fifth anniversary of the date of issuance.  The warrants include a cashless exercise provision as well as antidilution provisions with respect to certain securities issuances.

The Company received net cash proceeds of approximately $2,830,000, after the payment of offering related fees and expenses of $345,000.  Out of these proceeds, the Company repaid in full $1,100,000 of bridge loans issued in July 2007.  Pursuant to the terms of the 2007 Debentures, each holder has the right at any time until his note is fully paid to convert any outstanding and unpaid principal and accrued interest into shares of common stock at the conversion price per share equal to 75% of the average of the closing bid prices of the Company’s common stock for the 10 trading days preceding the conversion date, however, the conversion price shall not exceed $0.05 per share.  The conversion price and number and kind of shares or other securities to be issued upon conversion are subject to adjustment.

The subscription agreement entered into in connection with the issuance of the Company’s 2007 Debentures provides that in the event the Company issues any common stock at a price per share less than the stated conversion price in the 2007 Debentures (a “Lower Conversion Price”), without the consent of each of the 2007 Debenture holders, then the Company shall (i) in the event the holder has converted debentures or exercised warrants, issue additional shares to the holder so that the average price per share still held by the holder following conversion or exercise is equal to the Lower Conversion Price, and (ii) reset the conversion price of the outstanding 2007 Debentures and the exercise price of the outstanding warrants issued in connection with the 2007 Debentures to the Lower Conversion Price.  In addition, the terms of the 2007 Debentures provide that in the event the Company issues common stock for consideration less than the maximum conversion price at the time of issuance, the maximum conversion price will be reduced to the Lower Conversion Price.

In February 2008, the Company entered into a transaction in which shares were issued at $0.0155 per share, which resulted in the maximum conversion price for the 2007 Debentures and the exercise price of the warrants issued to the investors and the Finder resetting to $0.0155 per share.  The reduction of the warrant exercise price resulted in revaluing these warrants to $1,743,384 as of April 30, 2008. Subsequent to the period ended April 30, 2008, the Company issued shares at prices below $0.0155 per share in settlement of litigation.  The Company believes the issuance of these shares will also lower the conversion price of the 2007 Debentures and the exercise price of the related warrants; however, the entire impact of these transactions is unclear as of the date of this report (see Note 11).

Interest payable on the 2007 Debentures accrues at an annual rate of 10% and is payable on March 31, 2008 and quarterly thereafter, and on the maturity date, accelerated or otherwise, when the principal and remaining accrued but unpaid interest is due and payable, unless previously converted into common stock.  The Company has not paid the March 31, 2008 interest with respect to any of the 2007 Debentures.  However, nine of the funds (or 75.59% of the outstanding 2007 Debenture principal) deferred their March 31, 2008 interest payment to June 30, 2008 in exchange for a 10% increase in said interest payment.  One of the nine funds also agreed to convert its interest payment into common stock.  Based upon management’s estimate of the Company’s cash balance, it is probable that the Company will not be able to pay the June 30, 2008 interest payment which would result in an event of default under the subscription agreement. As a result, in accordance with EITF Issue No. 86-30, Classification of Obligations When a Violation Is Waived by the Creditor, all amounts outstanding under 2007 Debentures, net of debt discount, have been classified as current liabilities in the condensed consolidated balance sheet as of April 30, 2008.

The Company has the option of prepaying the outstanding principal on the 2007 Debentures, in whole or in part, by paying the holder(s) 130% of the principal amount to be redeemed, together with accrued but unpaid interest.

 
21

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2007 Debentures (Continued)

The Company paid Blumfield Investments (the “Finder”) a cash finder’s fee equal to $317,500 (10% of the aggregate purchase price for the 2007 Debentures issued).  An additional fee equal to 10% of any cash proceeds received by the Company from exercise of the warrants will be payable to the Finder upon exercise of the warrants.  The Company also agreed to issue to the Finder a warrant, in substantially the same form as the warrants issued to the holders of the 2007 Debentures, pursuant to which the Finder may purchase 10 shares of common stock for each 100 shares issuable upon conversion of the 2007 Debentures and warrants as of the closing date.  As a result, the Company has issued a warrant to the Finder pursuant to which the Finder may purchase up to 29,306,567 shares of common stock at an initial exercise price of $0.10 per share, valued at $497,277 on the issuance date.  The fair value of these warrants of $497,277 and the offering related fees and expenses of $345,000 were recorded as deferred financing costs and are being charged to interest expense over the term of the 2007 Debentures.  The exercise price of the Finder’s warrants are subject to adjustments similar to those applicable to the warrants issued to the investors in the 2007 Debentures, which are discussed above.  In February 2008, the Company entered into a transaction in which shares were issued at $0.0155 per share, which resulted in the exercise price for the Finder’s warrants resetting to $0.0155 per share.  Subsequent to the period ended April 30, 2008, the Company issued shares at prices below $0.0155 per share in settlement of litigation.  The Company believes the issuance of these shares will also lower the exercise price of the Finder’s warrants; however, the entire impact of these transactions is unclear as of the date of this report (see Note 11).

To secure the Company’s obligations under the 2007 Debentures, the Company has granted a security interest in substantially all of its assets, including without limitation, its intellectual property, in favor of the investors.  The security interest terminates upon payment or satisfaction of all of the Company’s obligations under the 2007 Debentures.

In connection with the sale of the 2007 Debentures, the Company agreed to prepare and file with the SEC, within 45 days following the closing date, a registration statement for the purpose of registering for resale a number of shares of common stock equal to 125% of the shares issuable upon conversion of the 2007 Debentures.  The registration rights agreed to in the 2007 Debenture transaction provided that should the Company fail to file such registration statement within such time, or if the registration statement was not declared effective within 150 days from the closing date, the Company would pay liquidated damages equal to 2% of the principal amount of the 2007 Debentures and purchase price of the related warrants for each 30 day period.  Such liquidated damages are payable in cash or registered shares of stock valued at 75% of the average closing bid prices over the preceding 5 day period.

The Company has not filed a registration statement and is not in compliance with the terms of the registration rights granted to holders of the 2007 Debentures.  However, during January 2008, the Company obtained waivers from 9 of the 12 holders of the 2007 Debentures (representing 75.59% of the outstanding 2007 Debenture principal) waiving such registration rights.

The Company accounts for the registration rights under FSP EITF 00-19-2, which specifies that the contingent obligation to make future payments or otherwise transfer consideration under a registration payment arrangement, whether issued as a separate agreement or included as a provision of a financial instrument or other agreement, should be separately recognized and measured in accordance with SFAS No. 5, “Accounting for Contingencies”. FSP EITF 00-19-2 also requires additional disclosure regarding the nature of any registration payment arrangements, alternative settlement methods, the maximum potential amount of consideration and the current carrying amount of the liability, if any.


 
22

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2007 Debentures (Continued)

The aggregate principal amount of $3,527,778 was recorded as a liability net of a debt discount of $352,778, which reflects the original issue discount of 10%, and a debt discount of $3,175,000 consisting of an allocation of the fair values attributed to the warrants issued to investors and to the embedded conversion feature in accordance with EITF Issue No. 00-19.  The debt discount of $3,175,000 consisted of a $2,116,667 value related to the warrants issued to investors and a value attributed to the embedded conversion feature of $1,058,333.  The debt discount was first allocated to the embedded conversion feature based on its fair value. After reducing the gross proceeds by the value attributed to the embedded conversion feature, the remaining unallocated debt discount of $2,116,667 was allocated to the warrants issued to investors.  The excess of the fair value of the warrants issued to investors above the debt discount allocated to these warrants was $369,721 and was recorded as interest expense.

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with SFAS No. 133 and EITF Issue No. 00-19. SFAS 133 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments in accordance with EITF Issue No. 00-19.  These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of SFAS 133. SFAS 133 and EITF Issue No. 00-19 also provide an exception to this rule when the host instrument is deemed to be conventional (as that term is described in the implementation guidance to SFAS 133 and further clarified in EITF Issue No. 05-2 “The Meaning of “Conventional Convertible Debt Instrument” in EITF Issue No. 00-19”.

The Company determined that the embedded conversion option and the warrants issued to the investors and the Finder are derivative liabilities.

During the three months ended April 30, 2008, accrued interest on the 2007 Debentures of $5,388 was converted into 603,712 shares of common stock. 

Included in interest expense for the three and six months ended April 30, 2008 is $429,510 and $704,590, respectively, related to the amortization of the debt discount on these debentures.

The 2007 Debentures are summarized below as of April 30, 2008: 

   
Outstanding
Principal
Amount
   
Unamortized
Debt
Discount
   
Net Carrying
Value
 
Current
 
$
3,527,778
   
$
2,823,188
   
$
704,590
 

2006 Debentures

On March 10, 2006, the Company raised gross proceeds of $6.0 million from a private placement to 17 institutional and individual investors (the “Investors”) of its two-year 7% Senior Secured Convertible Debentures (the “2006 Debentures”).  The 2006 Debentures originally were due and payable on March 10, 2008, but the maturity date was extended pursuant to agreements with the four remaining Investors.


 
23

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2006 Debentures (Continued)

Effective March 17, 2008, the Company entered into amendment agreements with two Investors holding 2006 Debentures with an aggregate principal amount of $200,000 (the “March 17 Amendments”). The March 17 Amendments amend the terms of the two subject 2006 Debentures to:  (1) extend the maturity date until September 17, 2008, (2) obligate the Company to pay all interest accrued on such debentures as of June 30, 2008 in cash; (3) extend the payment date for interest that will have accrued on such debentures as of June 30, 2008 until September 17, 2008; and (4) increase the outstanding amount of unconverted principal on such debentures by 20%, or $40,000, however, the 20% principal premium and interest accruing thereon must be paid in cash and may not be converted by such Investors into Company common stock.  The 20% principal premium was recorded in the consolidated statement of operations within operating expenses as an extension fee.  The March 17 Amendments also included waivers of any event of default that may have occurred under the terms of such 2006 Debentures prior to the date thereof.

Effective March 19, 2008, the Company entered into amendment agreements with two Investors holding unconverted 2006 Debentures with an aggregate principal amount of $425,000 (the “March 19 Amendments”).  In exchange for aggregate cash consideration of $23,181, the March 19 Amendments amend the terms of the two subject 2006 Debentures to extend the maturity date on such debentures until April 10, 2008.  The cash consideration of $23,181was recorded in the consolidated statement of operations within operating expenses as an extension fee.  The March 19 Amendments also included waivers of any event of default relating to failure to pay amounts due that may have occurred under the terms of such 2006 Debentures prior to the date thereof.

Effective April 17, 2008, the Company entered into amendment agreements with the two Investors that were parties to the March 19 Amendments (the “April 17 Amendments”).  In exchange for aggregate cash consideration of $23,181, the April 17 Amendments amend the terms of the two subject 2006 Debentures to extend the maturity date on such debentures until May 10, 2008.  The cash consideration of $23,181was recorded in the consolidated statement of operations within operating expenses as an extension fee.  The April 17 Amendments also included waivers of any event of default relating to failure to pay amounts due that may have occurred under the terms of such 2006 Debentures prior to the date thereof.

Effective May 29, 2008, the Company entered into amendment agreements with the two Investors that were parties to the March 19 Amendments (the “May 29 Amendments”).  In exchange for aggregate cash consideration of $23,181, the May 29 Amendments amend the terms of the two subject 2006 Debentures to extend the maturity date on such debentures until June 10, 2008.  The May 29 Amendments also included waivers of any event of default relating to failure to pay amounts due that may have occurred under the terms of such 2006 Debentures prior to the date thereof.

In June 2008, the Company reached an agreement with one Investor holding unconverted 2006 Debentures with an aggregate principal amount of $275,000 to extend the maturity date one month (the “June Extension”).  In exchange for aggregate cash consideration of $15,000, the June Extension amends the terms of the subject 2006 Debenture to extend the maturity date on such debenture until July 10, 2008.  The June Extension also included waivers of any event of default relating to failure to pay amounts due that may have occurred under the terms of such 2006 Debenture prior to the date thereof.

In June 2008, the Company reached an agreement with an Investor holding unconverted 2006 Debentures with an aggregate principal amount of approximately $150,000 (the “June Amendment”).  In the June Amendment, the maturity date of the subject 2006 Debenture was extended to June 30, 2009 and the variable conversion price of the subject 2006 Debenture was changed.  Such 2006 Debenture is convertible into shares of common stock at a conversion price for any such conversion equal to the lower of (x) 75% of the closing bid price of the common stock on the trading day immediately preceding the conversion date or (y) if the Company enters into certain financing transactions, the lowest purchase price or conversion price applicable to that transaction.  The conversion price is subject to adjustment.

 
24

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2006 Debentures (Continued)

In connection with the issuance of the 2006 Debentures, the Company issued to the Investors warrants to purchase 70,955,548 shares of the Company’s common stock at an exercise price of $0.15 per share valued at $9,036,727 on the issuance date (subject to adjustments for stock splits, stock dividends, recapitalizations, mergers, spin-offs, and certain other transactions).  The warrants are exercisable until the last day of the month in which the third anniversary of the effective date of the registration statement registering the shares underlying the warrants occurs (August 31, 2009).

The Company received net proceeds of approximately $5.31 million from the 2006 Debentures after the payment of offering related fees and expenses of approximately $690,000.  At the same time, from these proceeds, the Company repaid in full certain bridge loans made in December 2005 and January 2006, in the aggregate amount of $810,000.

Except for the 2006 Debenture that is subject to the June Amendment, the 2006 Debentures are convertible into shares of common stock at a conversion price for any such conversion equal to the lower of (x) 70% of the volume weighted average price (“VWAP”) of the common stock for the 20 days ending on the trading day immediately preceding the conversion date or (y) if the Company enters into certain financing transactions, the lowest purchase price or conversion price applicable to that transaction.  The conversion price is subject to adjustment.

Interest on the 2006 Debentures accrues at the rate of 7% per annum, payable upon conversion, or semi-annually (June 30 and December 31 of each year) or upon maturity, whichever occurs first, and will continue to accrue until the 2006 Debentures are fully converted and/or paid in full. Interest is payable, at the option of the Company, either (i) in cash, or (ii) in shares of common stock at the then applicable conversion price.

The Company agreed to include the shares of common stock issuable upon conversion of the 2006 Debentures and exercise of the related warrants issued to investors and the placement agent in a registration statement filed by the Company with the Securities and Exchange Commission (the “SEC”).  Since the registration statement was not declared effective by the SEC by June 23, 2006, the Company was obligated to pay liquidated damages to the holders of the 2006 Debentures.  A registration statement covering the common stock issuable upon conversion of the 2006 Debentures and the related warrants issued to investors and the placement agent was declared effective by the SEC on August 16, 2006.  These liquidated damages aggregated $212,000.  At their option, the holders of the 2006 Debentures are entitled to be paid such amount in cash or shares of restricted common stock at a per share rate equal to the effective conversion price of the 2006 Debentures at the time the liquidated damages became due.  During the six months ended April 30, 2007, 464,535 shares of common stock valued at $68,547 were issued as payment for liquidated damages.  Accrued liquidated damages as of April 30, 2008 was $143,453.

In connection with the placement of the 2006 Debentures, a placement agent received a placement agent fee equal to (i) 10% of the aggregate purchase price (i.e., $600,000), (ii) 10% of the proceeds realized in the future from exercise of warrants issued to the Investors, (iii) warrants to purchase an aggregate of 7,095,556 shares of common stock having an initial exercise price equal to $0.1693 per share valued at $888,779 on the issuance date, and (iv) warrants to purchase an aggregate of 7,095,556 shares of common stock having an initial exercise price equal to $0.15 per share valued at $903,673 on the issuance date.  The exercise price of the placement agent warrants is subject to adjustments for stock splits, stock dividends, recapitalizations, mergers, spin-offs, and certain other transactions.  The aggregate fair value of the placement agent’s warrants of $1,792,452 on the issuance date was recorded as a deferred financing cost and is being charged to interest expense over the term of the 2006 Debentures.

The gross proceeds of $6,000,000 are recorded as a liability net of a debt discount of $6,000,000 consisting of an allocation of the fair values attributed to the Investors’ warrants and to the embedded conversion feature in accordance with EITF Issue No. 00-19.  The debt discount consisted of a $3,428,571 value related to the Investors’ warrants and a value attributed to the embedded conversion feature of $2,571,429.  The debt discount was first allocated to the embedded conversion feature based on its fair value.  After reducing the gross proceeds by the value allocated to the embedded conversion feature, the remaining unallocated debt discount of $3,428,571 was allocated to the Investors’ warrants.

 
25

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2006 Debentures (Continued)

In accordance with SFAS No. 133 and EITF Issue No. 00-19, due to the possibility that an indeterminate number of shares could be issued upon conversion of the 2006 Debentures, the Company separately values and accounts for the embedded conversion feature related to the 2006 Debentures, the Investors’ warrants and the placement agent’s warrants as derivative liabilities.

During the six months ended April 30, 2008, $92,000 of principal amount of 2006 Debentures plus accrued interest of $26,844 were converted into 10,368,447 shares of common stock.  During the six months ended April 30, 2007, $3,931,000 of principal amount of 2006 Debentures plus accrued interest of $136,911 were converted into 56,376,123 shares of common stock.

As of April 30, 2008, the conversion option liability of $2,571,429 had been reduced to $240,000 as a result of conversions of the 2006 Debentures.  During the six months ended April 30, 2008, $39,429 was recorded as a reclassification to stockholders’ equity.  Since the issuance of the 2006 Debentures, an aggregate of $2,331,429 has been recorded as a reclassification to stockholders’ equity.

Included in interest expense for the three and six months ended April 30, 2008 is $34,786 and $116,843, respectively, related to the amortization of the debt discount on these debentures.  Included in interest expense for the three and six months ended April 30, 2007 is $80,599 and $2,831,187, respectively, related to the amortization of the debt discount on these debentures.

The 2006 Debentures are summarized below as of April 30, 2008:

   
Outstanding
Principal
Amount
   
Unamortized
Debt
Discount
   
Net Carrying
Value
 
Current
 
$
600,000
   
$
--
   
$
600,000
 

2005 Debentures

On May 26, 2005, the Company completed a private placement to certain individual and institutional investors of $3,500,000 in principal amount of its three-year 7% Senior Secured Convertible Debentures (the “2005 Debentures”).  All principal is due and payable on May 26, 2008. The 2005 Debentures are convertible into shares of common stock at a conversion price equal to the lower of (x) 70% of the 5 day volume weighted average price of the Company’s common stock immediately prior to conversion or (y) if the Company entered into certain financing transactions subsequent to the closing date, the lowest purchase price or conversion price applicable to that transaction.  As of the date of this Report, the Company has not repaid the $4,280 principal amount outstanding on the 2005 Debentures, which are currently in default.

Interest on the 2005 Debentures accrues at the rate of 7% per annum and is payable on a bi-annual basis, commencing December 31, 2005, or on conversion and may be paid, at the option of the Company, either in cash or in shares of common stock.  The Company may prepay the amounts outstanding on the 2005 Debentures by giving advance notice and paying an amount equal to 120% of the sum of (x) the principal being prepaid plus (y) the accrued interest thereon.

 
26

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

2005 Debentures (Continued)

In connection with the issuance of the 2005 Debentures, the Company issued to the purchasers thereof warrants (the “Investor Warrants”) to purchase 33,936,650 shares of common stock valued at $2,000,000 on the issuance date, with warrants for 11,312,220 shares being exercisable through the last day of the month in which the first anniversary of the effective date of the Registration Statement occurs (August 31, 2006) at a per share exercise price of $0.1547 and warrants for 22,624,430 shares being exercisable through the last day of the month in which the third anniversary of the effective date of the Registration Statement occurs (August 31, 2008) at a per share exercise price of $0.3094.

In connection with the issuance of the 2005 Debentures, the Company also issued to a placement agent warrants to purchase up to 5,656,108 shares of Common Stock (the “Compensation Warrants”) valued at $319,066 on the issuance date.  This amount was recorded as a deferred financing cost and is being charged to interest expense over the term of the 2005 Debentures. All of the Compensation Warrants were exercised in February 2006.

Holders of the Investor Warrants are entitled to exercise those warrants on a cashless basis following the first anniversary of issuance if the Registration Statement is not in effect at the time of exercise.

The gross proceeds of $3,500,000 were recorded net of a debt discount of $3,500,000.  The debt discount consisted of a $2,000,000 value related to the Investor Warrants and a $1,500,000 value related to the embedded conversion feature in accordance with SFAS No. 133 and EITF Issue No. 00-19.  Due to the possibility that an indeterminate number of shares could be issued upon conversion of the 2005 Debentures, the Company separately values and accounts for the embedded conversion feature related to the 2005 Debentures and the Investor Warrants as derivative liabilities.

During the six months ended April 30, 2007, $1,284 of principal amount of 2005 Debentures plus accrued interest of $37 were converted into 18,321 shares of common stock. 

As of April 30, 2008, the conversion option liability of $1,500,000 had been reduced to $1,834 as a result of conversions of the 2005 Debentures.  Since the issuance of the 2005 Debentures, an aggregate of $1,498,166 has been recorded as a reclassification to stockholders’ equity.

Included in interest expense for the three and six months ended April 30, 2008 is $349 and $705, respectively, related to the amortization of the debt discount on these debentures.  Included in interest expense for the three and six months ended April 30, 2007 is $345 and $1,375, respectively, related to the amortization of the debt discount on these debentures.

The 2005 Debentures are summarized below as of April 30, 2008:

   
Outstanding
Principal
Amount
   
Unamortized
Debt Discount
   
Net Carrying
Value
 
Current
 
$
4,280
   
$
119
   
$
4,161
 

7% Debentures

In December 2003, April 2004 and May 2004, the Company completed a private placement to certain private and institutional investors of $1,350,000 in principal amount of its three-year 7% Convertible Debentures (the “7% Debentures”).


 
27

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 5 - CONVERTIBLE DEBENTURES (CONTINUED)

7% Debentures (Continued)

Under the agreements with the purchasers of the 7% Debentures issued in December 2003, the Company is obligated to pay to the Debenture holders liquidated damages associated with the late filing of the Registration Statement and the missed Registration Statement required effective date of March 30, 2004.  Liquidated damages are equal to (x) 2% of the principal amount of all the Debentures during the first 30-day period following late filing or effectiveness and (y) 3% of the principal amount of all Debentures for each subsequent 30-day period (or part thereof). These liquidated damages aggregated to $160,000.  At the Company’s option, the Debenture holders are entitled to be paid such amount in cash or shares of Common Stock at a per share rate equal to the effective conversion price of the Debentures, which is currently $0.15.  Accrued liquidated damages as of April 30, 2008 was $37,550. 

During the six months ended April 30, 2008, $25,000 of principal amount of 7% Debentures plus accrued interest of $7,530 were converted into 2,098,709 shares of common stock.  As an inducement to convert, the Company agreed to reduce the conversion price to $0.0155 which resulted in the issuance of 1,881,842 additional shares of common stock.  Accordingly, the Company recorded additional interest expense of $37,637 during the three and six months ended April 30, 2008.

There was no amortization of debt discount on these debentures for the three and six months ended April 30, 2008.  Included in interest expense for the three and six months ended April 30, 2007 is $733 and $1,491, respectively, related to the amortization of the debt discount on these debentures.

The 7% Debentures are summarized below as of April 30, 2008: 

   
Outstanding
Principal
Amount
   
Unamortized
Debt Discount
   
Net Carrying
Value
 
Current
 
$
50,000
   
$
--
   
$
50,000
 

The remaining 7% Debentures outstanding at April 30, 2008, originally issued in May 2004, were due and payable in May 2007 and are currently in default.

NOTE 6 - NOTES PAYABLE

In May 2007, the Company entered into a promissory note resulting in gross proceeds of $400,000.  The promissory note was originally due and payable on August 22, 2007 and bears interest at the rate of 10% per annum.  The maturity date of this promissory note was initially extended to October 31, 2007.  On March 20, 2008, the Company entered into an agreement with the note holder pursuant to which the maturity date of the note was extended to July 31, 2008 and the note holder waived any default that may have existed.  In addition the Company agreed to use its best efforts to make minimum monthly principal and interest payments of $50,000 no later than the last calendar day of each month prior to the extended maturity date of July 31, 2008.  During the six months ended April 30, 2008, the Company repaid principal of $200,000 and accrued interest of $30,466.

NOTE 7 - STOCKHOLDERS’ DEFICIENCY

Common Stock

During the six months ended April 30, 2008, the Company:

 
·
issued 21,000,000 shares of restricted common stock in exchange for services valued at $471,000;


 
28

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 7 - STOCKHOLDERS’ DEFICIENCY (CONTINUED)

Common Stock (Continued)

 
·
issued 13,070,868 shares of common stock upon conversion of convertible debentures with a principal amount of $117,000 and accrued interest of $39,762;

 
·
issued 18,350,000 shares of restricted common stock in exchange for cash proceeds of $273,000;

 
·
issued 60,000,000 shares of common stock valued at $1,740,000 upon acquisition of BDSI; and

 
·
issued 150,000,000 shares of common stock valued at $1,975,000 upon acquisition of MCCI.

Options Granted

During the three months ended January 31, 2008, the following options were granted:

 
·
Options to purchase 500,000 shares of common stock were granted to three employees under the 2006 Plan. These options were valued at $12,581 and have a ten year term, an exercise price of $0.027 per share, and vest over a period of approximately three years through January 2011;

 
·
Options to purchase 250,000 shares of common stock were granted to an employee under the 2006 Plan. These options were valued at $5,628 and have a ten year term, an exercise price of $0.021 per share, and vest over a period of approximately three years through December 2010; and

 
·
Options to purchase 2,000,000 shares of common stock were granted to a director under the 2006 Plan.  These options were valued at $57,827 and have a ten year term, an exercise price of $0.031 per share, and vest over a period of approximately three years through January 2011.

During the three months ended April 30, 2008, no options were granted.

The weighted-average estimated fair value of stock options granted during the six months ended April 30, 2008 and 2007 was $0.03 and $0.09 per share, respectively, using the Black-Scholes model with the following assumptions:

 
April 30,
2008
 
April 30,
2007
Expected dividends
None
   
None
 
           
Expected volatility
110%
 
 
116%
 
           
Risk-free interest rate
3.88%
 
 
4.65%
 
           
Expected life
10 years
   
10 years
 

Options Forfeited

During the six months ended April 30, 2008, 3,096,505 options to employees were forfeited under the terms of their respective plans.


 
29

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 7 - STOCKHOLDERS’ DEFICIENCY (CONTINUED)

Warrants

In November 2007, the Company granted warrants to purchase 400,000 shares of common stock at an exercise price of $0.15 per share to an investor in connection with the issuance of restricted common stock.  The fair value of the stock warrants estimated on the date of grant using the Black-Scholes model is $0.025 per share or $9,947.

In December 2007, the Company granted warrants to purchase 175,839,399 shares of common stock at an exercise price of $0.10 per share to investors and the Finder in connection with the issuance of the 2007 Debentures (see Note 5).  The fair value of the stock warrants estimated on the date of grant using the Black-Scholes model is $0.017 per share or $2,983,665.

During the three months ended April 30, 2008, the Company granted warrants to purchase 17,503,759 shares of common stock at an exercise price of $0.15 per share to investors in connection with the issuance of restricted common stock.  The fair value of the stock warrants estimated on the date of grant using the Black-Scholes model is $0.008 per share or $132,616.

April 2007 Bridge Loan Warrants

In February 2008, the Company entered into a transaction in which shares were issued at $0.0155 per share.  As a result, the terms of the Company’s outstanding warrants issued in connection with its April 2007 Bridge Loan (the “April 2007 Bridge Loan Warrants”) repriced in accordance with a provision similar to the warrants issued in connection with the 2007 Debentures (see Note 5), which gives the holder of such warrants the benefit of the lowest price issued in a new transaction.  Therefore, the exercise price of the April 2007 Bridge Loan Warrants has been reset to $0.0155 and will reset again upon resolution of the Outboard Lawsuits valuation described in Note 11.  The reduction of the warrant exercise price resulted in revaluing the April 2007 Bridge Loan Warrants to $32,100 as of April 30, 2008.

Net Loss Per Share

Securities that could potentially dilute basic earnings per share (EPS), in the future, that were not included in the computation of diluted EPS because to do so would have been anti-dilutive for the periods presented, consist of the following:

 
As of
 
April 30,
2008
 
April 30,
2007
       
Warrants to purchase common stock
  320,356,095
 
  117,870,937
2007 Debentures and accrued interest (1)
406,782,739
 
--
2006 Debentures and accrued interest (2)
64,608,285
 
9,822,118
Options to purchase common stock
39,269,480
 
38,893,750
Convertible notes payable and accrued interest
1,447,940
 
1,508,927
7% Debentures and accrued interest
439,087
 
621,548
2005 Debentures and accrued interest (3)
979,298
 
120,685
       
Total
833,882,924
 
168,837,965

(1)
Based on a ten day average closing bid price for the common stock discounted by 25% as of April 30, 2008 of $0.0090.


 
30

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 7 - STOCKHOLDERS’ DEFICIENCY (CONTINUED)

Net Loss Per Share (Continued)

(2)
Based on a twenty day volume weighted average common stock price discounted by 30% as of April 30, 2008 and 2007 of $0.0089 and $0.06895, respectively.

(3)
Based on a five day volume weighted average common stock price discounted by 30% as of April 30, 2008 and 2007 of $0.0085 and $0.06678, respectively.

Substantial issuances after April 30, 2008 through June 20, 2008:

Common stock issued in settlement of litigation
   
125,000,000
 
         
Common stock issued in exchange for cash proceeds
   
9,500,000
 
         
Common stock issued upon conversion of convertible debentures
   
26,338,104
 
         
Warrants granted to purchase common stock
   
4,000,000
 

NOTE 8 - COMMITMENTS, CONTINGENCIES AND OTHER MATTERS

Concentration of Credit Risk

The Company maintains cash balances in one financial institution.  The balance is insured by the Federal Deposit Insurance Corporation up to $100,000 per institution.  From time to time, the Company’s balances may exceed these limits.  As of April 30, 2008, there were no uninsured balances.  The Company believes it is not exposed to any significant credit risk for cash.

NOTE 9 - ACCOUNTING FOR THE UNCERTAINTY IN INCOME TAXES

In July 2006, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109” (“FIN 48”), which clarifies the accounting and disclosure for uncertainty in tax positions, as defined.  FIN 48 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes.  This interpretation is effective for fiscal years beginning after December 15, 2006 and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return, and provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition.  As a result of the implementation of FIN 48, the Company recorded no adjustment for unrecognized income tax benefits.  At the adoption date of November 1, 2007 and also at April 30, 2008, the Company had no unrecognized tax benefits.  The Company classifies any interest and penalties related to income taxes as components of income tax expense.

The tax years 2003 to 2006 remain open to examination by the major taxing jurisdictions to which we are subject.  Preceding years also remain open to examination by U.S. federal and state revenue authorities to the extent of future utilization of net operating losses (NOLs) generated in each preceding year.

Utilization of the NOL may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously or that could occur in the future as provided by Section 382 of the Internal Revenue Code of 1986 and similar state provisions.  These ownership changes may limit the amount of NOL that can be utilized annually to offset future taxable income and tax.  In general, an ownership change, as defined in Section 382, results from transactions which increase the ownership of certain 5% or greater shareholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period.  Since the Company’s formation, the

 
31

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 9 - ACCOUNTING FOR THE UNCERTAINTY IN INCOME TAXES (CONTINUED)

Company has raised capital through the issuance of capital stock and convertible debenture on several occasions which, combined with the purchasing shareholders’ subsequent disposition of those shares, may have resulted in a change of control, as defined in Section 382, or could result in a change of control in the future upon subsequent disposition.  The Company’s income tax return reflects the entire NOL without any limitation per Section 382.

The Company has completed a preliminary evaluation of its income tax return position in conjunction with its adoption of FIN 48.  Based upon this analysis, the Company believes that it is more likely than not that a change of control under Section 382 has occurred.  As a result, effective November 1, 2007, the Company reduced the carrying amount of its Deferred Tax Asset and related valuation allowance from approximately $23 million to $8 million for the tax effect of reducing its NOL from approximately $57.5 million to $20.7 million for financial reporting purposes.

During the six months ended April 30, 2008, the Company issued 210,000,000 shares of its common stock to UTEK Corp. as discussed in Note 3.  Under guidance provided by Section 382, the Company determined that the issuance of those shares, along with the issuance of additional shares of stock in connection with other transactions, more likely than not resulted in a change of control.  Accordingly, the Company further reduced the carrying amount of its Deferred Tax Asset and related valuation allowance from approximately $8 million to $3.2 million for the tax effect of reducing its NOL from approximately $20.7 million to $8 million.

The Company has not completed its formal evaluation of its Section 382 matters.  The effect of this change did not have any effect on the carrying value of the deferred tax asset which is fully offset by a valuation allowance.

NOTE 10 – RELATED PARTY TRANSACTIONS

From time to time during the six months ended April 30, 2008, the Company was advanced funds by an officer of the Company.  These advances are non-interest bearing.  At April 30, 2008, amounts due to the officer were $49,000 and are reflected on the accompanying condensed consolidated balance sheet as “advance from officer.”

NOTE 11 – SUBSEQUENT EVENTS

Equity Transactions

In May 2008, the Company issued:
 
(i)  
4,500,000 shares of common stock to three investors for total cash proceeds of $45,000;
(ii)  
1,185,712 shares of common stock to one investor upon conversion of 2006 Debentures with a principal amount of $10,000 and interest of $250;
(iii)  
65,000,000 shares of common stock in settlement of two lawsuits with an investor holding 2006 Debentures with an aggregate principal amount of $50,000; and
(iv)  
Warrants to purchase 4,000,000 shares of common stock at an exercise price of $0.15 per share were granted to investors in connection with the issuance of restricted common stock.  The fair value of the stock warrants estimated on the date of grant using the Black-Scholes model is $0.007 per share or $28,008.

In June 2008, the Company issued:
 
(i)  
24,017,875 shares of common stock upon conversion of 2007 Debentures with a principal amount of $62,791 and interest of $14,795;
(ii)  
1,134,517 shares of common stock upon conversion of 2006 Debentures with a principal amount of $5,000 and interest of $162;

 
32

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 11 – SUBSEQUENT EVENTS (CONTINUED)

Equity Transactions (Continued)

(iii)  
5,000,000 shares of restricted common stock in exchange for cash proceeds of $75,000; and
(iv)  
60,000,000 shares of restricted common stock in settlement of one lawsuit with an investor holding 2006 Debentures with a principal amount of $25,000 and interest of $786.

Issuance of Promissory Notes

In June 2008, the Company entered into promissory notes resulting in gross proceeds of $112,000.  The promissory notes are due and payable one year from the date of the notes and bear interest at the rate of 10% per annum.

Reduction of Principal Amount of 2006 Debentures; Settlement of Litigation

In May and June 2008, the Company was a party to three separate lawsuits filed by Outboard Investments, Ltd. (“Outboard”), an assignee of a portion of $500,000 in 2006 Debentures originally held by Double U Master Fund, L.P.  Outboard filed the lawsuits in the Circuit Court for the Twelfth Judicial Circuit in and for Sarasota County, Florida (the “Outboard Lawsuits”) on May 8, 2008 (the “First Outboard Lawsuit”), May 29, 2008 (the “Second Outboard Lawsuit”) and June 12, 2008 (the “Third Outboard Lawsuit”).  In each of the Outboard Lawsuits, the plaintiff alleged that it was damaged by the Company’s failure to perform according to the terms of the 2006 Debentures.  Due to a lack of sufficient cash to satisfy the claims made and to defend such lawsuits, and without admitting any wrongdoing, the Company agreed to settle each of the Outboard Lawsuits by the payment of common stock.  These shares were issued without registration in reliance upon Section 3(a)(10) of the Securities Act.  On May 8, 2008, May 29, 2008 and June 12, 2008, respectively, the Florida court approved the settlements of the First Outboard Lawsuit, Second Outboard Lawsuit and Third Outboard Lawsuit, respectively, and the fairness of each settlement to Outboard.  In settlement of the First Outboard Lawsuit, the Company issued 25 million shares of common stock.  This resulted in the cancellation of $25,000 in principal plus interest of the 2006 Debentures.  In settlement of the Second Outboard Lawsuit, the Company issued 40 million shares of common stock.  This resulted in the cancellation of $25,000 of principal and interest owed under the 2006 Debentures.  In settlement of the Third Outboard Lawsuit, the Company issued 60 million shares of common stock.  This resulted in the cancellation of $25,786 in principal and interest owed under the 2006 Debentures.  The settlement of the Outboard Lawsuits resulted in a reduction of $75,000 in principal amount owed on the 2006 Debentures by the Company.

Change in Conversion Price

The subscription agreement entered into in connection with the issuance of the Company’s 2007 Debentures provides that in the event the Company issues any common stock to a person or entity at a price per share less than the stated conversion price in the 2007 Debentures (a “Lower Conversion Price”), without the consent of each of the 2007 Debenture holders, then the Company shall (i) in the event the holder has converted debentures or exercised warrants, issue additional shares to the holder so that the average price per share still held by the holder following conversion or exercise is equal to the Lower Conversion Price, and (ii) reset the conversion price of the outstanding 2007 Debentures and the exercise price of the outstanding warrants issued in connection with the 2007 Debentures to the Lower Conversion Price.  In addition, the terms of the 2007 Debentures provide that in the event the Company issues common stock for consideration less than the maximum conversion price at the time of issuance, the maximum conversion price will be reduced to the Lower Conversion Price.  In February 2008, the Company issued shares at a price of $0.0155 per share, which resulted in the resetting of the conversion price to no higher than $0.0155.  The Company believes that the issuance of shares in connection with the settlement of the Outboard Lawsuits also results in the lowering of the conversion price and maximum conversion price for the 2007 Debentures and the exercise price of the warrants issued in connection therewith.  However, due to ambiguities in the subscription agreement and the circumstances surrounding the issuances of shares in connection with the Outboard Lawsuits, it is unclear as to how the shares issued in the Outboard Lawsuits will be valued.

 
33

 
RIM SEMICONDUCTOR COMPANY AND SUBSIDIARIES
(A Development Stage Company Commencing November 1, 2007)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


NOTE 11 – SUBSEQUENT EVENTS (CONTINUED)

Change in Conversion Price (Continued)

Therefore, it is unclear what price the conversion price, the maximum conversion price and warrant exercise price will reset to with respect to the 2007 Debentures.  The Company intends to engage in discussions with the holders of the 2007 Debentures to clarify and resolve this issue.

In addition, the terms of the Company’s outstanding warrants issued in connection with its April 2007 Bridge Loan (the “April 2007 Bridge Loan Warrants”) have repriced in accordance with a similar provision, which gives the holder of such warrants the benefit of the lowest price issued in a new transaction.  Therefore, the exercise price of the April 2007 Bridge Loan Warrants has been reset to $0.0155 and will reset again upon resolution of the Outboard Lawsuits valuation described above.

The Company does not believe the shares issued in settlement of the Outboard Lawsuits should be valued based solely upon the value of the 2006 Debenture principal and interest that was cancelled as part of each settlement.  If the valuation was made on that basis, however, the lowest price at which shares could be deemed issued by the Company would be $0.00043 per share, and the conversion price and maximum conversion price for the 2007 Debentures, the exercise price of the warrants issued in connection therewith, and the exercise price of the April 2007 Bridge Loan Warrants would reset to that price.  If the exercise price of all such warrants were reduced to $0.00043 per share, the Company would recognize a gain based on the change in fair value of the warrants.  At June 20, 2008, the amount of such gain would have been approximately $1,591,000.

Increase in Authorized Shares

On June 3, 2008 shareholders approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares from 900,000,000 to 4,000,000,000.

There is an inverse relationship between the Company’s stock price and the number of shares issuable upon conversion of the Company’s debentures.  That is, the higher the market price of the common stock at the time a debenture is converted, the fewer shares the Company would be required to issue, and the lower the market price of the common stock at the time a debenture is converted, the more shares the Company would be required to issue.  If the maximum conversion price of the 2007 Debentures is reduced as a result of the issuance of stock in the Outboard Lawsuit settlements, or the Company’s stock price does not improve, the Company would need to further increase the number of shares of common stock authorized in order to honor its obligations to issue shares to the debenture holders and other holders of options, warrants, convertible promissory notes and other derivative securities.

Resignation of David R. Wojcik

Effective June 2, 2008, David R. Wojcik resigned as Senior Vice President Sales, Marketing and Business Development in order to pursue other business opportunities.  Mr. Wojcik’s Employment Agreement dated September 1, 2006 has also been terminated and the Company is under no obligation to make severance payments to him.  Options held by Mr. Wojcik to purchase up to 4,000,000 shares of common stock are forfeited unless exercised by August 31, 2008.  As of June 2, 2008, Mr. Wojcik was due from the Company $48,125 for accrued compensation and expenses.

 
34

 

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

We urge you to read the following discussion in conjunction with our condensed consolidated financial statements and the notes thereto included elsewhere herein.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Our prospects are subject to uncertainties and risks. In this Quarterly Report on Form 10-QSB, we make forward-looking statements in this Item 2 and elsewhere that also involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and reflect our beliefs and assumptions based upon information available to us at the date of this report. In some cases, you can identify these statements by words such as “if,” “may,” “might,” “will, “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” and other similar terms. These forward-looking statements include, among other things, projections of our future financial performance and our anticipated growth, descriptions of our strategies, our product and market development plans, the trends we anticipate in our business and the markets in which we operate, and the competitive nature and anticipated growth of those markets.

We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to the risks and uncertainties discussed in our other filings with the SEC. We undertake no obligation to revise or update any forward-looking statement for any reason.

OVERVIEW

Rim Semiconductor Company (the “Company,” “we,” “our,” or “us”), a development stage company, has developed advanced transmission technology products to enable data to be transmitted across copper telephone wire at speeds and over distances that exceed those offered by leading DSL technology providers.  In September 2005, the Company changed its name from New Visual Corporation to Rim Semiconductor Company. Our common stock trades on the OTC Bulletin Board under the symbol RSMI. Our corporate headquarters are located at 305 NE 102nd Avenue, Portland, Oregon 97220 and our telephone number is (503) 257-6700.

Our first chipset in a planned family of transport processors, the Cu5001 digital signal processor, is commercially available in FPGA form.  We are presently working on the ASSP version of the semiconductor. We market this technology to leading equipment makers in the telecommunications industry. Our products are designed to substantially increase the capacity of existing copper telephone networks, allowing telephone companies, office building managers, and enterprise network operators to provide enhanced and secure video, data and voice services over the existing copper telecommunications